Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
Mind Medicine Inc (NASDAQ: MNMD) closed the day trading at $12.22 down -0.89% from the previous closing price of $12.33. In other words, the price has decreased by -$0.89 from its previous closing price. On the day, 1.43 million shares were traded. MNMD stock price reached its highest trading level at $12.4519 during the session, while it also had its lowest trading level at $11.7601.
Ratios:
For a better understanding of MNMD, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.98 and its Current Ratio is at 4.98. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.22.
On January 28, 2025, Evercore ISI started tracking the stock assigning a Outperform rating and target price of $23.
On December 20, 2024, Chardan Capital Markets started tracking the stock assigning a Buy rating and target price of $20.Chardan Capital Markets initiated its Buy rating on December 20, 2024, with a $20 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 25 ’25 when Sullivan Mark sold 11,278 shares for $9.77 per share. The transaction valued at 110,186 led to the insider holds 293,852 shares of the business.
Barrow Robert sold 25,797 shares of MNMD for $252,037 on Sep 25 ’25. The Chief Executive Officer now owns 804,268 shares after completing the transaction at $9.77 per share. On Sep 25 ’25, another insider, Karlin Daniel, who serves as the Chief Medical Officer of the company, sold 7,704 shares for $9.77 each. As a result, the insider received 75,268 and left with 430,625 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MNMD now has a Market Capitalization of 929794688 and an Enterprise Value of 787992640.
Stock Price History:
The Beta on a monthly basis for MNMD is 3.44, which has changed by 1.1938958 over the last 52 weeks, in comparison to a change of 0.16766965 over the same period for the S&P500. Over the past 52 weeks, MNMD has reached a high of $12.70, while it has fallen to a 52-week low of $4.70. The 50-Day Moving Average of the stock is 24.77%, while the 200-Day Moving Average is calculated to be 58.20%.
Shares Statistics:
Over the past 3-months, MNMD traded about 1.35M shares per day on average, while over the past 10 days, MNMD traded about 2245150 shares per day. A total of 75.80M shares are outstanding, with a floating share count of 72.57M. Insiders hold about 4.01% of the company’s shares, while institutions hold 54.42% stake in the company. Shares short for MNMD as of 1757894400 were 10692593 with a Short Ratio of 7.95, compared to 1755216000 on 10293064. Therefore, it implies a Short% of Shares Outstanding of 10692593 and a Short% of Float of 14.16.
Earnings Estimates
The market rating of Mind Medicine Inc (MNMD) is currently shaped by the ongoing analysis conducted by 6.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.52, with high estimates of -$0.43 and low estimates of -$0.63.
Analysts are recommending an EPS of between -$1.61 and -$1.95 for the fiscal current year, implying an average EPS of -$1.77. EPS for the following year is -$1.81, with 7.0 analysts recommending between -$1.0 and -$2.47.
